Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125835201 | 12583520 | 1 | I | 200810 | 20160711 | 20160722 | 20160722 | EXP | JP-DEPOMED, INC.-JP-2016DEP011456 | DEPOMED | KANAO-KANDA M, KANDA H, TAKAHATA O, KUNISAWA T. A CASE OF GAIT DISTURBANCE CAUSED BY LOW-DOSE GABAPENTIN. THER CLIN RISK MANAGE.. 2016;12:927-929 | 60.00 | YR | M | Y | 0.00000 | 20160722 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125835201 | 12583520 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 200 MG, BID | Y | Y | 22544 | 200 | MG | ||||||
| 125835201 | 12583520 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 200 MG, BID | Y | Y | 22544 | 200 | MG | ||||||
| 125835201 | 12583520 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100 MG, BID | Y | Y | 22544 | 100 | MG | ||||||
| 125835201 | 12583520 | 4 | I | SODIUM VALPROATE | VALPROATE SODIUM | 1 | Oral | 1200 MG, QD | 0 | 1200 | MG | ||||||||
| 125835201 | 12583520 | 5 | I | SODIUM VALPROATE | VALPROATE SODIUM | 1 | 0 | ||||||||||||
| 125835201 | 12583520 | 6 | I | SODIUM VALPROATE | VALPROATE SODIUM | 1 | 0 | ||||||||||||
| 125835201 | 12583520 | 7 | I | SODIUM VALPROATE | VALPROATE SODIUM | 1 | 0 | ||||||||||||
| 125835201 | 12583520 | 8 | I | FLUNITRAZEPAM | FLUNITRAZEPAM | 1 | Oral | 0.5 MG, QD, BEFORE BEDTIME | 0 | .5 | MG | ||||||||
| 125835201 | 12583520 | 9 | C | LOXOPROFEN | LOXOPROFEN | 1 | 180 MG, UNK | 0 | 180 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125835201 | 12583520 | 1 | Neuralgia |
| 125835201 | 12583520 | 4 | Muscular weakness |
| 125835201 | 12583520 | 5 | Pain |
| 125835201 | 12583520 | 6 | Paralysis |
| 125835201 | 12583520 | 7 | Epilepsy |
| 125835201 | 12583520 | 8 | Insomnia |
| 125835201 | 12583520 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125835201 | 12583520 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125835201 | 12583520 | Drug interaction | |
| 125835201 | 12583520 | Gait disturbance | |
| 125835201 | 12583520 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125835201 | 12583520 | 1 | 20081021 | 200810 | 0 | |
| 125835201 | 12583520 | 2 | 20081025 | 200810 | 0 | |
| 125835201 | 12583520 | 3 | 20081027 | 0 | ||
| 125835201 | 12583520 | 8 | 1986 | 0 |